Crossmark

Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block

Crossref DOI link: https://doi.org/10.1136/openhrt-2024-002606

Published Online: 2024-03-27

Published Print: 2024-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Cannie, Douglas https://orcid.org/0000-0001-6298-922X
Patel, Kush

Protonotarios, Alexandros

Heenan, Imogen

Bakalakos, Athanasios https://orcid.org/0009-0006-6356-2205
Syrris, Petros

Menezes, Leon

Elliott, Perry M
Funding

Funding for this research was provided by:

British Heart Foundation (FS/CRTF/20/24022)

Pfizer Limited (WI246510)
License Information

License valid from 2024-03-27